Document is current
Any future updates will be listed below
-
Authors
Okkels, Anna
Yssing, Cecilie
Wolden, Michael Lyng
Wahid, Mohd Nawi
-
Funding
Funding for this research was provided by:
Novo Nordisk, 2860 Søborg, Denmark
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 28 October 2024
First Online: 13 November 2024
Declarations
:
: This study was not a clinical trial, did not include patients and did not gather biological or human samples or identifiable personal information, and ethical review board approval was therefore not required. All respondents gave consent to participate before answering the surveys.
: Not applicable.
: Medical writing support was provided by AO and CY from EY Godkendt Revisionspartnerselskab, Denmark, and funded by Novo Nordisk. Publication review support was provided by AXON Communications, London, UK, and funded by Novo Nordisk. MLW and MNW are employees of Novo Nordisk, and MLW owns stocks in Novo Nordisk. AO and CY received funding for performing the study and medical writing support but were not paid for their role as author.
